摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(4-hexylphenoxy)acetic acid | 3280-63-5

中文名称
——
中文别名
——
英文名称
2-(4-hexylphenoxy)acetic acid
英文别名
——
2-(4-hexylphenoxy)acetic acid化学式
CAS
3280-63-5
化学式
C14H20O3
mdl
——
分子量
236.311
InChiKey
LPYHDHGKBRMYBL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.5
  • 重原子数:
    17
  • 可旋转键数:
    8
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    46.5
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-(4-hexylphenoxy)acetic acid氯化亚砜 作用下, 以 为溶剂, 反应 3.0h, 以96%的产率得到2-(4-hexylphenoxy)acetyl chloride
    参考文献:
    名称:
    恶二唑-异丙基酰胺作为有效的非共价蛋白酶体抑制剂
    摘要:
    对 50 000 ChemBridge 化合物库的筛选导致鉴定出恶二唑-异丙基酰胺1 (PI-1833),其抑制胰凝乳蛋白酶样 (CT-L) 活性(IC 50 = 0.60 μM),对其他两种主要蛋白酶体几乎没有影响蛋白水解活性,胰蛋白酶样 (TL) 和谷氨酰肽水解样 (PGPH-L)。LC-MS/MS 和透析表明1是一种非共价且快速可逆的 CT-L 抑制剂。集中文库合成为11ad (PI-1840) 提供了 CT-L 活性 (IC 50= 27 纳米)。详细的 SAR 研究表明酰胺部分和两个苯环对修饰敏感。疏水性残基,如在对位丙基或丁基(未邻位或间位)的A环和一个的米-吡啶基团作为B环,显著提高活性。化合物11ad (IC 50 = 0.37 μM)在抑制完整 MDA-MB-468 人乳腺癌细胞中的 CT-L 活性和抑制其存活方面比1 (IC 50 = 3.5 μM)更有效。11ad的活
    DOI:
    10.1021/jm400221d
  • 作为产物:
    描述:
    参考文献:
    名称:
    Kakhniashvili,A.T.; Bugianishvili,D.Ya., Journal of Organic Chemistry USSR (English Translation), 1965, vol. 1, p. 1051 - 1054
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Preparation and unique circular dichroism phenomena of urea-functionalized self-folding resorcinarenes bearing chiral termini through asymmetric hydrogen-bonding belts
    作者:Osamu Hayashida、Jun-ichi Ito、Shinji Matsumoto、Itaru Hamachi
    DOI:10.1039/b418880b
    日期:——
    Chiral macrocycles with eight (R)- and (S)-methylbenzylurea residues on the resorcinarene skeleton linked through a hexyl or dodecyl spacer having amide linkages have been prepared by the reactions of the corresponding octaamine derivative with (R)- and (S)-α-methylbenzylisocyanate, respectively. In chloroform, the urea-functionalized resorcinarenes with hexyl spacers form intramolecular hydrogen bonds by bundling the urea and amide residues in a cyclic fashion to give a self-folding cavitand. The urea and amide residues are cooperatively oriented in the same direction to result in asymmetric hydrogen-bonding belts. Unique circular dichroism (CD) bands are induced in the absorption wavelength ranges of the macrocyclic skeleton, caused by a chirality transmission from their chiral urea termini through hexyl spacers in the self-folded conformation. On the other hand, urea-functionalized resorcinarenes with a longer dodecyl spacer do not show such unique CD bands on the macrocycle, because of their weaker propensity for hydrogen bond formation. The characteristic CD bands of the urea-functionalized self-folding macrocycles disappeared upon complexation with anions such as chloride and bromide, reflecting breaking of the intramolecular hydrogen-bonding belts.
    通过相应的八胺衍生物分别与(R)-和(S)-α-甲基苄基异氰酸酯的反应,制备出了在间苯二酚骨架上有八个(R)-和(S)-甲基苄基残基的手性大环,这些残基通过具有酰胺键的己基或十二烷基间隔物连接。在氯仿中,带有己基间隔的官能化间苯二酚通过将和酰胺残基以环状方式捆绑在一起形成分子内氢键,从而得到一种自折叠空穴剂。和酰胺残基在同一方向上相互配合,形成不对称的氢键带。在大环骨架的吸收波长范围内,会出现独特的圆二色性(CD)带,这是由于在自折叠构象中,手性末端通过己基间隔产生了手性传递。另一方面,具有较长十二烷基间隔的官能化间苯二酚由于氢键形成的倾向性较弱,在大环上不会显示出这种独特的 CD 带。官能化自折叠大环与化物和化物等阴离子络合后,其特征性 CD 带消失,这反映了分子内氢键带的断裂。
  • Urea-functionalized Resorcinarenes: Preparation, Self-folding, and Their CD Phenomena Caused by Chiral Urea Termini through Intramolecular Hydrogen Bonding Interactions
    作者:Osamu Hayashida、Jun-ichi Ito、Shinji Matsumoto、Itaru Hamachi
    DOI:10.1246/cl.2004.994
    日期:2004.8
    Self-folding resorcinarenes bearing optically active urea moieties showed unique circular dichroism (CD) phenomena on the macrocyclic skeleton, which were caused by their chiral urea termini through intramolecular hydrogen bonding interactions in chloroform. These characteristic CD bands were disappeared upon complexation with anions such as chloride and bromide.
    含有光学活性分子的自折叠间苯二酚在大环骨架上显示出独特的圆二色性(CD)现象,这是由其手性末端在氯仿中通过分子内氢键相互作用引起的。与化物和化物等阴离子络合后,这些特征性 CD 带消失了。
  • PROTEASOME CHYMOTRYPSIN-LIKE INHIBITION USING PI-1833 ANALOGS
    申请人:H. Lee Moffitt Cancer Center and Research Institute, Inc
    公开号:US20140073650A1
    公开(公告)日:2014-03-13
    Focused library synthesis and medicinal chemistry on an oxadiazole-isopropylamide core proteasome inhibitor provided the lead compound that strongly inhibits CT-L activity. Structure activity relationship studies indicate the amide moiety and two phenyl rings are sensitive toward synthetic modifications. Only para-substitution in the A-ring was important to maintain potent CT-L inhibitory activity. Hydrophobic residues in the A-ring's para-position and meta-pyridyl group at the B-ring significantly improved inhibition. The meta-pyridyl moiety improved cell permeability. The length of the aliphatic chain at the para position of the A-ring is critical with propyl yielding the most potent inhibitor, whereas shorter (i.e. ethyl, methyl or hydrogen) or longer (i.e. butyl, propyl and hexyl) chains demonstrating progressively less potency. Introduction of a stereogenic center next to the ether moiety (i.e. substitution of one of the hydrogens by methyl) demonstrated chiral discrimination in proteasome CT-L activity inhibition (the S-enantiomer was 35-40 fold more potent than the R-enantiomer).
    聚焦于氧代二唑-异丙酰胺核心蛋白酶抑制剂的合成和药物化学,提供了一种强烈抑制CT-L活性的先导化合物。结构活性关系研究表明,酰胺基团和两个苯环对合成修饰非常敏感。只有在A环上的对位取代对维持强效的CT-L抑制活性至关重要。A环对位的疏基团和B环的间吡啶基团显著提高了抑制作用。间吡啶基团提高了细胞渗透性。A环对位的脂肪链长度是关键,丙基产生了最有效的抑制剂,而较短(即乙基,甲基或氢)或较长(即丁基,异丙基和己基)的链逐渐表现出较少的效力。在醚基团旁引入一个立体异构中心(即将一个氢原子取代为甲基)表明在蛋白酶体CT-L活性抑制中具有手性歧视(S-对映体比R-对映体更有效,效力提高了35-40倍)。
  • Proteasome chymotrypsin-like inhibition using PI-1833 analogs
    申请人:H. Lee Moffitt Cancer Center and Research Institute, Inc.
    公开号:US10662180B2
    公开(公告)日:2020-05-26
    Focused library synthesis and medicinal chemistry on an oxadiazole-isopropylamide core proteasome inhibitor provided the lead compound that strongly inhibits CT-L activity. Structure activity relationship studies indicate the amide moiety and two phenyl rings are sensitive toward synthetic modifications. Only para-substitution in the A-ring was important to maintain potent CT-L inhibitory activity. Hydrophobic residues in the A-ring's para-position and meta-pyridyl group at the B-ring significantly improved inhibition. The meta-pyridyl moiety improved cell permeability. The length of the aliphatic chain at the para position of the A-ring is critical with propyl yielding the most potent inhibitor, whereas shorter (i.e. ethyl, methyl or hydrogen) or longer (i.e. butyl, propyl and hexyl) chains demonstrating progressively less potency. Introduction of a stereogenic center next to the ether moiety (i.e. substitution of one of the hydrogens by methyl) demonstrated chiral discrimination in proteasome CT-L activity inhibition (the S-enantiomer was 35-40 fold more potent than the R-enantiomer).
    通过对一种噁二唑-异丙基酰胺核心蛋白酶抑制剂进行重点文库合成和药物化学研究,获得了能强烈抑制 CT-L 活性的先导化合物。结构活性关系研究表明,酰胺分子和两个苯基环对合成修饰很敏感。只有 A 环中的对位取代对保持 CT-L 的强效抑制活性非常重要。A 环的对位疏残基和 B 环的元吡啶基能显著改善抑制作用。偏吡啶基提高了细胞渗透性。A 环对位脂肪族链的长度至关重要,丙基产生的抑制作用最强,而较短的链(即乙基、甲基或氢基)或较长的链(即丁基、丙基和己基)的抑制作用则逐渐减弱。在醚分子旁边引入一个立体中心(即用甲基取代其中一个氢)可在蛋白酶体 CT-L 活性抑制方面显示出手性差异(S-对映体的效力比 R-对映体高 35-40 倍)。
  • Cholesterol-Solubilizing Agents Related to the Gallstone Problem
    作者:C. Ainsworth、D. N. Benslay、J. Davenport、J. L. Hudson、D. Kau、T. M. Lin、R. R. Pfeiffer
    DOI:10.1021/jm00314a006
    日期:1967.3
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫